Important Announcement
PubHTML5 Scheduled Server Maintenance on (GMT) Sunday, June 26th, 2:00 am - 8:00 am.
PubHTML5 site will be inoperative during the times indicated!

Home Explore PANDEMICS EPIDEMICS presentation by greek team

PANDEMICS EPIDEMICS presentation by greek team

Published by ng, 2021-05-14 19:08:25

Description: PANDEMICS EPIDEMICS presentation by greek team

Search

Read the Text Version

PANDEMICS EPIDEMICS We Will Survive eTwinning 2020-2021

Pandemic Control Measures

Preventive Measures 01 Quarantine 02 Social Distance 03 Use of Face Masks 04 Improved Ventilation Danae GREECE

COVID-19 vaccines BioNTech-Pfizer Moderna AstraZeneca Janssen 2019.04 (Johnson & Johnson) Vaccines are a most powerful tool in ensuring public health, and COVID-19 vaccines can be expected to play an important role in contributing to control the pandemic. Nickie GREECE

CLINICAL TRIAL PHASES There are three clinical trial phases for efficacy and safety before a vaccine can be approved for use by humans. The phases differ from each other, most significantly in their scale: In Phase I, a vaccine is tested on small patient groups. In Phase II, a vaccine is tested on larger groups of at least 100 patients; researchers can also test their candidate vaccine in specific subgroups, such as people with preexisting conditions, or patients with particular demographic characteristics, such as a higher age group. In Phase III, a vaccine candidate is tested on at least 1,000 patients. MICHAEL GREECE

COVID-19 PANDEMIC Pfizer is collaborating with Traditional vaccines use a German biotech company dead or a weakened BioNTech to focus on a pathogenic microbe or a toxin technology called an mRNA from a pathogen. The vaccine. Unlike conventional introduction of an attenuated vaccines, which can take or dead pathogen into a months to produce by healthy individual generates growing weakened forms of an immune response. the virus, RNA vaccines can be constructed quickly using Vaccines aid in creating a only the pathogen's genetic memory of the antigenic specificity of disease in the code. individual, thus immunizing the individual against that ANDREW GREECE particular disease for a long period.

THE FASTEST VACCINE DEVELOPMENT DEVELOPMENT JOHN GREECE


Like this book? You can publish your book online for free in a few minutes!
Create your own flipbook